Ximeceff 50mg Syrup contains Cefixime, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The syrup formulation facilitates ease of administration, particularly in pediatric and geriatric patients who may have difficulty swallowing tablets. Ximeceff 50mg Syrup is typically administered orally, with dosage and duration determined by the severity and type of infection as well as patient age and renal function. It is generally well tolerated; however, potential side effects include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions including rash and pruritus. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Renal impairment may necessitate dosage adjustment. This medication should be used under medical supervision, and the full prescribed course must be completed to prevent the development of resistant bacterial strains. Ximeceff 50mg Syrup is contraindicated in patients with known hypersensitivity to cefixime or other cephalosporins.